Citigroup’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-98,646
Closed -$21M 7875
2014
Q4
$21M Buy
98,646
+5,227
+6% +$1.04M 0.02% 777
2014
Q3
$16.6M Sell
93,419
-80,413
-46% -$13.4M 0.01% 918
2014
Q2
$29.4M Sell
173,832
-25,537
-13% -$3.98M 0.03% 568
2014
Q1
$24.7M Sell
199,369
-24,125
-11% -$2.94M 0.03% 598
2013
Q4
$24.8M Buy
223,494
+21,287
+11% +$2.03M 0.02% 662
2013
Q3
$18.3M Sell
202,207
-113,668
-36% -$10.2M 0.02% 787
2013
Q2
$26.6M Buy
+315,875
New +$32.8M 0.03% 547

Other funds holding AGN

Citigroup's AGN Position: Q1 2015 in Review

Citigroup sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 98,646 shares — an estimated $21M sold.

Citigroup first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $29.4M in Q2 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Citigroup reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Citigroup sold 98,646 Allergan Inc shares in Q1 2015, an estimated $21M.
  • Citigroup first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Citigroup's Allergan Inc position peaked at $29.4M in Q2 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Citigroup's 13F filing for Q1 2015, filed 14 May 2015.